1. Home
  2. DOMO vs STIM Comparison

DOMO vs STIM Comparison

Compare DOMO & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Domo Inc. Class B

DOMO

Domo Inc. Class B

N/A

Current Price

$3.84

Market Cap

132.7M

Sector

Technology

ML Signal

N/A

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

N/A

Current Price

$2.80

Market Cap

120.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DOMO
STIM
Founded
2010
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.7M
120.4M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
DOMO
STIM
Price
$3.84
$2.80
Analyst Decision
Buy
Strong Buy
Analyst Count
9
1
Target Price
$10.28
$3.00
AVG Volume (30 Days)
1.2M
1.3M
Earning Date
05-20-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
31.92
57.25
EPS
N/A
N/A
Revenue
$318,857,000.00
$52,776,000.00
Revenue This Year
$3.41
$11.10
Revenue Next Year
$4.72
$11.92
P/E Ratio
N/A
N/A
Revenue Growth
0.57
N/A
52 Week Low
$1.84
$0.80
52 Week High
$18.49
$3.44

Technical Indicators

Market Signals
Indicator
DOMO
STIM
Relative Strength Index (RSI) 57.42 50.50
Support Level $3.32 $2.67
Resistance Level $4.05 N/A
Average True Range (ATR) 0.15 0.20
MACD 0.00 -0.05
Stochastic Oscillator 75.31 23.73

Price Performance

Historical Comparison
DOMO
STIM

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Share on Social Networks: